To increase government control of prescription drugs, the Biden administration has been threatening to exercise "March-in rights" on them.
Included in Bayh-Dole was a provision that allows the government to "March in" and steal patent rights if a patent holder "Has commercialized the product, but the price or other terms at which the product is currently offered to the public are not reasonable," particularly in the case of a national emergency.
That's according to a recent study finding that "99% of the therapies in our cohort cannot be marched-in upon, as the key patents studied do not cover the entire asset's intellectual property. There are only 5 out of 361 pharmaceutical products in which all available MoA and CoM patents include a government interest statement and could be subject to march-in rights."
"Progressives" have long demanded that the federal government exert march-in rights to seize drug patents and impose price controls - just like Hugo Chavez did while he was destroying Venezuela.
If a government curtails a research organization's financial incentives for developing a new technology, that organization will stop researching.
Biden is once again demagoguing drug prices to manipulate people into supporting him and weaponizing government to help his reelection.
We need to protect innovators from the federal government marching in and stealing their work.
No comments:
Post a Comment